Barclays’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$3K	–	5734
2020 Q1	$3K	Sell	100 -28,200	-100%	-$1.49M	﹤0.01%	5986
2019 Q4	$1.69M	Buy	28,300 +21,000	+288%	+$944K	﹤0.01%	3179
2019 Q3	$268K	Sell	7,300 -500	-6%	-$19.8K	﹤0.01%	4749
2019 Q2	$363K	Buy	7,800 +500	+7%	+$23.5K	﹤0.01%	4605
2019 Q1	$293K	Sell	7,300 -100	-1%	-$4.49K	﹤0.01%	4541
2018 Q4	$340K	Sell	7,400 -21,100	-74%	-$1.02M	﹤0.01%	4173
2018 Q3	$1.26M	Buy	28,500 +27,700	+3,463%	+$1.27M	﹤0.01%	3402
2018 Q2	$31K	Sell	800 -27,200	-97%	-$1.37M	﹤0.01%	5944
2018 Q1	$2.02M	Buy	28,000 +23,300	+496%	+$1.71M	﹤0.01%	2444
2017 Q4	$309K	Sell	4,700 -1,200	-20%	-$64.6K	﹤0.01%	4305
2017 Q3	$296K	Buy	5,900 +3,700	+168%	+$178K	﹤0.01%	4090
2017 Q2	$102K	Sell	2,200 -400	-15%	-$14.7K	﹤0.01%	4890
2017 Q1	$92K	Buy	+2,600	New	+$59.5K	﹤0.01%	4936
2015 Q3	–	Sell	-9,600	Closed	-$778K	–	6883
2015 Q2	$778K	Sell	9,600 -10,400	-52%	-$1.02M	﹤0.01%	3107
2015 Q1	$1.84M	Buy	+20,000	New	+$1.29M	﹤0.01%	2397